See every side of every news story

Published 2 years ago • loading... • Updated 2 years ago

MDMA warning as tablets circulating in UK found with three times the normal dose

Summary by Ground News

A number of red ecstacy pills, embossed with 'M5 Competition', have been tested. Analysis showed they contain two-and-a-half to three times the common oral dose of MDMA, between 252 - 276 mg per tablet. Manchester Drug Analysis and Knowledge Exchange (MANDRAKE) urged people who become unwell to 'seek medical attention'

2 Articles

2 Articles

All

Left

1

Center

1

Right

MDMA warning as tablets circulating in UK found with three times the normal dose

A warning has been made over red ecstasy pills embossed with "M5 Competition" that have been found circulating in Manchester and have up to three times the normal dosage

2 years ago·London, United Kingdom

Read Full Article

Manchester Evening News

MDMA pill with THREE times the normal dose is 'circulating in Manchester'

A number of red ecstacy pills, embossed with 'M5 Competition', are reportedly being sold in Manchester

2 years ago·Manchester, United Kingdom

Read Full Article

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/year

Stories disproportionately reported by the Left or the Right

Coverage Details

Total News Sources2

Leaning Left1Leaning Right0Center1Last Updated2 years agoBias Distribution

50% Left, 50% Center

Bias Distribution

50% of the sources lean Left, 50% of the sources are Center

50% Center

Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Manchester Evening News broke the news in Manchester, United Kingdom 2 years ago on Thursday, October 5, 2023.

Sources are mostly out of (0)

Similar News Topics

Stories disproportionately reported by the Left or the Right

Similar News Topics

You have read out of your 5 free daily articles.

Join us as a member to unlock exclusive access to diverse content. Stay informed with comprehensive global news coverage all in one place. Subscribe now to compare different perspectives, identify biases, and stay ahead of algorithms